Tag: Endpoints News

Jessica Grossman

IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...

IgGenix, a San Francisco-based biotech company, announced yesterday they had secured $40 million in Series B funding to bring a peanut allergy candidate to...